Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Sun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Sun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

Shares of Sun Pharmaceutical Industries fell sharply after ET reported the company had submitted a $12-billion binding offer for Organon & ...

Sun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...

Biocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...

Sun Pharma, India's largest drug maker, said it expects its innovative products to garner $1.5 billion in sales in the next 3-4 years.

Mandaviya said that the NFI 2021 would act as a guidance document for all the healthcare professionals such as clinicians, pharmacists, nur...

This is the second drug developed by Hetero after Covifor, the generic version of Remdesivir injection to be administered intravenously in ...

The company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.

The Drug Controller General of India has passed an order removing an alert notice for the use of Roche’s Avastin (bevacizumab) injection to...

Roche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...

After gaining market access under a USFDA contingency plan, Sun Pharma is awaiting approval for its cancer drug Lipodox.

American drug company Allergan Pharmaceuticals is setting up a wholly-owned subsidiary to sell Botox products, used as muscle relaxants and...